Related Experiment Video
Updated: May 30, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Improving severe sepsis outcomes: cost and time to first antibiotic dose
Robert W Hutchison1, D Angeleena Govathoti, Kyle Fehlis
1PharmD, Texas A&M Health Science Center, Rangel College of Pharmacy, 319 SRPH Administration Bldg, MS-1266, College Station, TX 77843, USA. Hutchison@tamhsc.edu
Abstract:
This study was conducted to determine the effect of an empiric antimicrobial guide on clinical and economic outcomes related to severe sepsis. As all critical care nurses know, severe sepsis is often life-threatening. The study found that an empiric antimicrobial guide specific for severe sepsis was associated with a reduced length of stay, a significantly earlier time to first dose antibiotic, and significantly lower total and variable hospital costs.
More Related Videos
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Dosage Interval and Administration Route: Determination Methods
Urine Studies II: Urine Culture and Sensitivity Test
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...

